Prostate Cancer
Accuray Launches First Study to Compare CyberKnife(R) SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
Published in Cancer Weekly, May 8th, 2012
2012 MAY 8 -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced the launch of the Prostate Advances in Comparative Evidence (PACE) Study, an international, multi-center, randomized study to compare CyberKnife® Stereotactic Body Radiation Therapy (SBRT), da Vinci assisted and manual laparoscopic surgery and conventionally fractionated intensity modulated radiation therapy (IMRT), for the treatment of localized prostate cancer. The PACE Study aims to build upon the strong foundation of published evidence for CyberKnife prostate SBRT by creating comparative evidence to support its future potential as the gold standard in the treatment of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2012-05-08)
More Articles from Cancer Weekly
- Breast Cancer
Cellular 'glue' resists breast cancer - Lung Cancer
Data from A.O. Ada and Colleagues Advance Knowledge in Lung Cancer - Carcinoid Tumors
Data from University of Alabama Provide New Insights into Carcinoid Tumors - Bladder Cancer
Data on Bladder Cancer Detailed by Researchers at Harvard University - Laryngeal Cancer
Data on Laryngeal Cancer Detailed by Researchers at Department of Head and Neck - Lip Cancer
Data on Lip Cancer Reported by Researchers at Sapienza University - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
